Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately

Clinical trial NCT01457508 · COMPLETED

Trial details

NCT number: NCT01457508
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis B Diphtheria Haemophilus Influenzae Type b (Hib)Poliomyelitis Pertussis Tetanus

Start date: 1999-01-01
Primary completion: 2000-03-01
Enrollment: 440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.